Valuation (45%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 30.84 | N/A |
| PEG Ratio (TTM) | 4.87 | N/A |
| P/S Ratio (TTM) | 10.63 | N/A |
| P/B Ratio (TTM) | 6.20 | N/A |
| P/FCF Ratio (TTM) | 30.30 | N/A |
| Price to 5YR AVG Earnings Ratio | 33.71 | N/A |
| Price to 5YR AVG FCF Ratio | 32.22 | N/A |
Profitability (95%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 15.20% | N/A |
| ROE (TTM) | 20.93% | N/A |
| Net Profit Margin (TTM) | 34.30% | N/A |
| ROIC 5YR AVG | 46.34% | N/A |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 7.54% | 16.30% | 9.77% |
| Revenue | 4.94% | 17.86% | 12.23% |
| Net Income | 7.63% | 16.93% | 10.19% |
| Cash Flow | 604.11% | 13.54% | 11.71% |
Health (74%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.58 | N/A |
| Quick Ratio (TTM) | 3.58 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | 115.62 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 14.28 | N/A |
| LTL to 5YR AVG FCF | 0.25 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.32% | N/A |